Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports

Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports

Abstract Background The advent of well-tolerated and effective anti-retroviral drugs against human immunodeficiency virus-1 (HIV-1) infection has been a major step forward that has achieved long-term survival in recent years. The number of HIV-1 infected patients who experience difficulty in swallow...

Full description

Bibliographic Details
Main Authors: Takefumi Suzuki, Nobuko Hara, Morichika Osa, Kazuhisa Misawa, Kazuo Imai, Yuji Fujikura, Takuya Maeda, Wataru Sonehara, Akihiko Kawana
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Dolutegravir
Rilpivirine
Dysphagia
NRTI-sparing
Online Access:http://link.springer.com/article/10.1186/s40780-017-0093-8

Internet

http://link.springer.com/article/10.1186/s40780-017-0093-8

Similar Items